Small clinical trials : issues and challenges

Cancer clinical trials : a commonsense guide to experimental cancer therapies and clinical trials

Harnessing science advancing care by accelerating the rate of cancer clinical trial participation : hearing before the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, second session, May 13, 2004.

Improper Medicare billing by hospitals nationwide for investigational devices and procedures : hearing before the Permanent Subcommittee on Investigations of the Committee on Governmental Affairs, United States Senate, One Hundred Fourth Congress, second session, February 14, 1996.

New drug approval FDA's consideration of evidence from certain clinical trials : report to congressional requesters.

Publication and disclosure issues in antidepressant pediatric clinical trials hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, September 9, 2004.

Extending Medicare reimbursement in clinical trials

Adequacy of access to investigative drugs for seriously ill patients : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, September 23, 1997.

Protections for foster children enrolled in clinical trials hearing before the Subcommittee on Human Resources of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.

From test tube to patient : new drug development in the United States.

Clinical research : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fourth Congress, second session, special hearing.

Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998.

Institutional review boards, a system in jeopardy : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, June 11, 1998.

Samantha who? The complete second and final season

The right to try : how the federal government prevents Americans from getting the life-saving treatments they need

A delicate balance FDA and the reform of the medical device approval process : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, April 13, 2011.

Small clinical trials : issues and challenges

Cancer clinical trials : a commonsense guide to experimental cancer therapies and clinical trials

Harnessing science advancing care by accelerating the rate of cancer clinical trial participation : hearing before the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, second session, May 13, 2004.

Improper Medicare billing by hospitals nationwide for investigational devices and procedures : hearing before the Permanent Subcommittee on Investigations of the Committee on Governmental Affairs, United States Senate, One Hundred Fourth Congress, second session, February 14, 1996.

New drug approval FDA's consideration of evidence from certain clinical trials : report to congressional requesters.

Publication and disclosure issues in antidepressant pediatric clinical trials hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, September 9, 2004.

Extending Medicare reimbursement in clinical trials

Adequacy of access to investigative drugs for seriously ill patients : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, September 23, 1997.

Protections for foster children enrolled in clinical trials hearing before the Subcommittee on Human Resources of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.

From test tube to patient : new drug development in the United States.

Clinical research : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fourth Congress, second session, special hearing.

Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998.

Institutional review boards, a system in jeopardy : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, June 11, 1998.

Samantha who? The complete second and final season

The right to try : how the federal government prevents Americans from getting the life-saving treatments they need

A delicate balance FDA and the reform of the medical device approval process : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, April 13, 2011.